Definitive Contract 75F40119C10045
Award Date 7/19/19
Potential Completion Date 3/31/22
Potential Value $902K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to the National Academy of Sciences (NAS), a non-profit organization, is for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. The $949,037 definitive contract, awarded by the Food and Drug Administration, a civilian agency, is for a 1.5-year period ending in January 2025. The contract does not have a set-aside designation. NAS frequently partners with other non-profit organizations, federally...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the National Academy of Sciences (NAS), a nonprofit organization chartered by Congress to provide expert advice and analysis on matters of science, technology, and health policy. The $125,694.17 firm fixed price contract is for the NAS to provide research, analysis, advisory, and technical support services to the FDA. No set-aside designation was used. The NAS has a long history...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to the National Academy of Sciences (NAS), a non-profit organization, on July 22, 2020 for $110,000.00. The contract is for the "Harmonization of Work to Produce Animal Nutrition Reports" under the HHS Cost Efficiency Initiative. The contract has an ultimate completion date of August 20, 2025 and was not set aside for any specific business type. NAS is the prime contractor on this...
- This federal contract award was issued by the Food and Drug Administration (FDA) to the National Academy of Sciences (NAS), a private non-profit organization, to provide expert advisory services and research support. The contract, valued at $100,000.00, was issued as a Blanket Purchase Agreement (BPA) call with a cost-no-fee pricing type. The contract has no set-aside designation. NAS is a trusted, non-partisan advisor to the government and frequently receives federal contracts and grants to...
- The Department of Health and Human Services Food and Drug Administration awarded a $1,309,126.30 definitive, cost-no-fee contract to the National Academy of Sciences, a non-profit organization, to conduct a "HORMONES STUDY" with a completion date of September 23, 2020. The contract did not have a set-aside designation. The National Academy of Sciences has a history of providing various research, analysis, advisory, and technical support services to federal agencies through prime and...
- This is a definitive contract awarded by the Food and Drug Administration (FDA) to the National Academy of Sciences (NAS) to facilitate the Food and Nutrition Board Forum. The $125,000.00 firm fixed-price contract does not have a set-aside designation. The contract provides a platform for representatives from government, industry, academia, and public interest groups to openly communicate about nutrition, food safety, and cosmetics issues. As a private, nonprofit institution, NAS often...
- The National Academy of Sciences (NAS), a non-profit organization, was awarded a $100,000.00 Firm Fixed Price Definitive Contract by the Food and Drug Administration (FDA) to conduct a review of Dietary Reference Intakes for Energy. This contract has no set-aside designation. NAS frequently receives federal contracts and grants to provide expert advisory services and technical support across various domains, including public health, for government agencies. The contract has a performance...
- The Food and Drug Administration (FDA) awarded a delivery order to the National Academy of Sciences (NAS) valued at $1.91 million for Protein Efficiency Ratio (PER) and growth monitoring studies to satisfy quality factor requirements. This contract, which carries a cost-no-fee pricing structure, includes a no-cost modification extending the period of performance through February 14, 2026. The work is being performed in Washington, DC, and no set-aside designation was applied to this award. The...
- This is a delivery order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to the National Academy of Sciences (NAS), a private non-profit organization. The contract is for the FORUM ON DRUG DISCOVERY, DEVELOPMENT AND TRANSLATION and has a ceiling value of $1,467,365.62. It is a cost-no-fee type contract with an ultimate completion date of December 23, 2024. The contract does not have a set-aside designation. NAS is a trusted, non-partisan advisor to the...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to the National Academy of Sciences (NAS), a private non-profit organization, for $75,000.00. The contract is for "EVIDENCE SCANNING FOR DRI NUTRIENTS" and has an ultimate completion date of August 31, 2021. The contract does not have a set-aside designation. NAS is a trusted advisor to the government, frequently receiving federal contracts and grants to provide research, analysis,...
The U.S. Food and Drug Administration (FDA) awarded a $901,888.19 definitive contract to the National Academy of Sciences (NAS), a non-profit organization, to produce a consensus report that identifies innovative technologies to advance pharmaceutical manufacturing. The contract, which is not set aside, was awarded on July 19, 2019 with a completion date of March 31, 2022. The report will assist the FDA's Center for Drug Evaluation and Research (CDER) in fostering the adoption of innovative technologies by pharmaceutical companies. The contract was awarded sole-source under FAR Part 5.203 and FAR 6.302.
Generated 3/24/24, 2:07 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Consensus Report on "Emerging Technology for Pharmaceutical Manufacturing" | FDA-19-1214278 | Department of Health and Human Services Food and Drug Administration | Pre-Solicitation 1/2 | 5/15/19, 9:16 PM | |
Consensus Report on "Emerging Technology for Pharmaceutical Manufacturing" | FDA-19-1214278 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 2/2 | 7/19/19, 3:31 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | ($87k) | 1/12/23 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 12/1/21 | |
| P00002 | Other Administrative Action | $0 | 11/1/21 | |
| P00001 | Change Order | $0 | 6/4/21 | |
| Not listed | Not listed | $989.4k | 7/19/19 |